Allelic length of a CA dinucleotide repeat in the egfr gene correlates with the frequency of amplifications of this sequence - First results of an inter-ethnic breast cancer study

Journal of Pathology

Volumn 203, Issue 1, 2004, Pages 545-550

  Buerger, Horst ^a   Packeisen, Jens ^b   Boecker, Almuth ^a   Tidow, Nicola ^a   Kersting, Christian ^a   Bielawski, Krzysztof ^c   Isola, Jorma ^d   Yatabe, Yasushi ^e   Nakachi, Kei ^f   Boecker, Werner ^a   Brandt, Burkhard ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b Institute of Pathology   (Germany)

^c UNIVERSITY OF GDA SK   (Poland)

^d UNIVERSITY OF TAMPERE   (Finland)

^e AICHI CANCER CENTER HOSPITAL   (Japan)

^f SAITAMA CANCER CENTER   (Japan)

Author keywords

Epidemiology; Epidermal growth factor receptor; Polymorphism

Indexed keywords

ADENINE; CYTOSINE; EPIDERMAL GROWTH FACTOR RECEPTOR; MICROSATELLITE DNA; NUCLEASE;

ALLELE; ALLELIC IMBALANCE; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER PATIENT; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DATA ANALYSIS; DINUCLEOTIDE REPEAT; DNA DETERMINATION; DNA POLYMORPHISM; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNOLOGY; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GERMANY; HEREDITY; HUMAN; HUMAN TISSUE; INTRON; JAPAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; REGULATORY SEQUENCE; STATISTICAL ANALYSIS;

ALLELES; BREAST NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, ERBB-1; GERMANY; HUMANS; INTRONS; JAPAN; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; NUCLEIC ACID HYBRIDIZATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 11144357461     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1542     Document Type: Article

References (28)

1. Buerger H, Gebhardt F, Schmidt H, et al. Length and loss of heterozygosity of an intron 1 polymorphic sequence of egfr is related to cytogenetic alterations and EGFR-expression. Cancer Res 2000; 60: 854-857.
2. Harris AL, Nicholson S, Sainsbury R, Wright C, Farndon J. Epidermal growth factor receptor and other oncogenes as prognostic markers. J Natl Cancer Inst Monogr 1992; 11: 181-187.
3. Harris AL, Nicholson S, Sainsbury JR, Farndon J, Wright C. Epidermal growth factor receptors in breast cancer: association with early relapse and death, poor response to hormones and interactions with neu. J Steroid Biochem 1989; 34: 123-131.
4. Fitzgibbons PL, Page DL, Weaver D, et al. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000; 127: 966-978.
5. Gebhardt F, Zanker KS, Brandt B. Modulation of epidermal growth factor receptor gene transcription by a polymorphic dinucleotide repeat in intron 1. J Biol Chem 1999; 274: 13 176-13 180.
6. Tidow N, Boecker A, Schmidt H, et al. Distinct amplification of an untranslated regulatory sequence in the egfr gene contributes to early steps in breast cancer development. Cancer Res 2003; 63: 1172-1178.
7. Liu W, Innocenti F, Chen P, Das S, Cook EH Jr, Ratain MJ. Interethnic difference in the allelic distribution of human epidermal growth factor receptor intron 1 polymorphism. Clin Cancer Res 2003; 9: 1009-1012.
8. Brandt B, Hermann S, Straif K, Tidow N, Buerger H, Chang-Claude J. Modification of breast cancer risk in young women by a polymorphic sequence in the egfr gene. Cancer Res 2004; 64: 7-12.
9. Zhang W, Stoehlmacher J, Park DJ, et al. A polymorphic dinucleotide repeat in intron 1 of EGFR (epidermal growth factor receptor) gene is associated with clinical response to platinum based chemotherapy in patients with advanced colorectal disease. Proc Am Soc Clin Oncol 2002; 21: 134a.
10. Fukuoka M, Yano S, Giaccone G, et al. Final results from the phase II trial of ZD1839 (Iressa) for patients with advanced non-small-cell lung cancer (IDEAL1). Proc Am Soc Clin Oncol 2002; 21: 298a.
11. Chi DD, Hing AV, Helms C, Steinbrueck T, Mishra SK, Donis KH. Two chromosome 7 dinucleotide repeat polymorphisms at gene loci epidermal growth factor receptor (EGFR) and pro alpha 2 (I) collagen (COL1A2). Hum Mol Genet 1992; 1: 135.
12. Canzian F, Salovaara R, Hemminki A, Kristo P, Aaltonen LA, de la Chapelle A. Semiautomated assessment of loss of heterozygosity and replication error in tumors. Cancer Res 1996; 56: 3331-3337.
13. Brandt B, Vogt U, Schlotter CM, et al. Prognostic relevance of aberrations in the erbB oncogenes from breast, ovarian, oral and lung cancers: double-differential polymerase chain reaction (ddPCR) for clinical diagnosis. Gene 1995; 159: 35-42.
14. Pollack JR, Sorlie T, Peron CM, et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci U S A 2002; 99: 12 963-12 968.
15. Dancey JE, Freidlin B. Targeting epidermal growth factor receptor - are we missing the mark? Lancet 2003; 362: 62-64.
16. Dowsett M, Bartlett J, Ellis IO, et al. Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centres. J Pathol 2003; 199: 418-423.
17. Solbach C, Roller M, Budischewski K, et al. EGF-R and Her2/neu overexpressing tumors: independent collectives for treatment of breast cancer by specific monoclonal antibody-therapy. J Cancer Res Clin Oncol 2003; 129: 250-251.
18. Korsching E, Packeisen J, Agelopoulos K, et al. Cytogenetic alterations and cytokeratin expression patterns in breast cancer - integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesis. Lab Invest 2002; 82: 1525-1533.
19. Hyman E, Kauraniemi P, Hautaniemi S, et al. Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res 2002; 62: 6240-6245.
20. Lee JS, Ro JS, Eisbruch A, et al. Multiple restriction fragment length polymorphisms of the human epidermal growth factor receptor gene. Cancer Res 1988; 48: 4045-4048.
21. Ro J, North SM, Gallick GE, Hortobagyi GN, Gutterman JU, Blick M. Amplified and overexpressed epidermal growth factor receptor gene in uncultured primary human breast carcinoma. Cancer Res 1988; 48: 161-164.
22. Chrysogelos SA, Dickson RB. EGF receptor expression, regulation, and function in breast cancer. Breast Cancer Res Treat 1994; 29: 29-40.
23. Fung LF, Wong N, Tang N, et al. Genetic imbalances in pT2 breast cancers of southern Chinese women. Cancer Genet Cytogenet 2001; 124: 56-61.
24. Tirkkonen M, Tanner M, Karhu R, Kallioniemi A, Isola J, Kallioniemi OP. Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosomes Cancer 1998; 21: 177-184.
25. Isola JJ, Kallioniemi OP, Chu LW, et al. Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. Am J Pathol 1995; 147: 905-911.
26. Eckert KA, Yan G, Hile SE. Mutation rate and specificity analysis of tetranucleotide microsatellite DNA alleles in somatic human cells. Mol Carcinog 2002; 34: 140-150.
27. Tsutsui S, Ohno S, Murakami S, Hachitanda Y, Oda S. Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer. Breast Cancer Res Treat 2002; 71: 67-75.
28. Brown NM, Wang J, Cotroneo MS, Zhao YX, Lamartiniere CA. Prepubertal genistein treatment modulates TGF-alpha, EGF and EGF-receptor mRNAs and proteins in the rat mammary gland. Mol Cell Endocrinol 1998; 144: 149-165.